Skip to main navigation Skip to search Skip to main content

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer

  • Thomas E. Delea
  • , Jon Karnon
  • , Oleg Sofrygin
  • , Simu K. Thomas
  • , Natalie L. Papo
  • , Victoria Barghout

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)608-618
Number of pages11
JournalClinical Breast Cancer
Volume7
Issue number8
DOIs
Publication statusPublished - 2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this